CARBON X-RAY · PHARMA & HEALTHCARE

Cohance Lifesciences: carbon disclosure.

What Cohance Lifesciences published, drawn only from its own SEBI BRSR and XBRL filings.

Ticker: COHANCE (NSE)Revenue: ₹1,094 cr (FY2024-25)Latest BRSR: FY2025-26
Summary

Cohance Lifesciences disclosed Scope 1 emissions of 56,324 tCO2e and Scope 2 emissions of 63,712 tCO2e in its FY2025-26 BRSR filing. It published a Scope 3 figure of 108,204 tCO2e, reported as a single total without a category breakdown. Its BRSR Core attributes carry reasonable assurance, provided by Sustainability Actions Private Limited. It holds SBTi-validated emission reduction targets.

AS FILED

The disclosure record.

Every row is taken from the company's own filings. Where a row says not published, it means no figure was found in the filings reviewed, which is not the same as the company having no such figure.

DisclosureAs filed
Scope 156,324 tCO2e
Scope 263,712 tCO2e
Scope 3108,204 tCO2e
Scope 3 by categoryNot published in the filings reviewed
BRSR Core assuranceReasonable assurance confirmed (Sustainability Actions Private Limited)
SBTiTargets validated
CDPNot published in the filings reviewed
Net-zero target year2050
Renewable electricity6.4%
Methodology documentedYes
SECTOR CONTEXT

How Pharma & Healthcare discloses.

54companies in this sector in the index
68.5%publish a Scope 3 figure
40.7%carry confirmed BRSR Core assurance

Across all 1,246 Indian BRSR filers, 65.2% publish a Scope 3 figure and 43.4% carry confirmed reasonable assurance. Full method and figures in The State of Carbon Disclosure in India.

WHAT IT MEANS

Where the pressure lands next.

Based on the filings reviewed, the items not yet published are Scope 3 split by GHG Protocol category. Reasonable assurance on BRSR Core reaches the top 1,000 listed entities in FY 2026-27, and an assurer works back from each reported figure to the document behind it.

Is this your company? Run the full diagnostic, free.

Run a Carbon X-Ray →
FAQS

Common questions.

Does Cohance Lifesciences disclose Scope 3 emissions?

Yes. Cohance Lifesciences published a Scope 3 figure of 108,204 tCO2e, as a single total without a category breakdown.

Are Cohance Lifesciences's carbon numbers assured?

Yes. Its BRSR Core attributes carry reasonable assurance, provided by Sustainability Actions Private Limited. Reasonable assurance is the higher of the two assurance levels and requires substantive testing back to source documents.

Where does this data come from?

SEBI BRSR and XBRL filings, BRSR Core assurance statements, the SBTi target dashboard and the CDP registry. Only figures the company itself published are attributed to it. Data as at 2026-09-25. Corrections to growth@climes.io.

Source: Cohance Lifesciences FY2025-26 BRSR and XBRL filings, plus the SBTi and CDP registries. Compiled by Climes. This page reports what the company published and does not assess the accuracy of those figures.